GSK3B and diabetes mellitus: Dysregulation of GSK-3β expression leads to many pathological conditions, including diabetes (or insulin resistance), neuronal dysfunction, Alzheimer's disease [15–18], schizophrenia [19], Dopamine-associated behaviors [20], bipolar disorders [21], Parkinson's disease [22], and cancer.